The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells
Open accessAbstract
This paper describes the in vitro cytotoxicity assessment of single walled carbon nanotubes (SWCNT) on A549 cells, a human lung cell line. Cellular viability was determined using the alamar blue (AB), neutral red (NR) and MTT assays, which evaluated metabolic, lysosomal and mitochondrial activity respectively. In addition, the total protein content of the cells was measured using the coomassie brilliant (CB) blue assay. Supernatants were also assayed for Adenylate Kinase (AK) release and Interleukin 8 (IL-8) which indicated a loss of cell membrane integrity and an inflammation response respectively. To investigate the interactions between serum components in the test medium and the test materials, exposures were conducted both in serum containing (5%) and serum-free medium. Results from the cytotoxicity tests (AB, CB, MTT) revealed the SWCNT to have very low acute toxicity to the A549 cells as all but one of the reported 24h EC(50) values exceeded the top concentration tested (800 microg/ml). The SWCNT were found to interfere with a number of the dyes used in the cytotoxicity assessment and we are currently conducting a comprehensive spectroscopic study to further investigate these interactions. Of the multiple cytotoxicity assays used, the AB assay was found to be the most sensitive and reproducible. Transmission electron microscopy (TEM) studies confirmed that there was no intracellular localization of SWCNT in A549 cells following 24h exposure; however, increased numbers of surfactant storing lamellar bodies were observed in exposed cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Lam, C.-W. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg243 · Cited by 1,991
Comparative Pulmonary Toxicity Assessment of Single-wall Carbon Nanotubes in Rats
Warheit, D. B. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg228 · Cited by 1,515
Cytotoxicity of Carbon Nanomaterials: Single-Wall Nanotube, Multi-Wall Nanotube, and Fullerene
Jia, G., Wang, H., Yan, L., Wang, X., Pei, R., Yan, T., Zhao, Y., & Guo, X. (2005) · Environmental Science & Technology · doi:10.1021/es048729l · Cited by 1,404
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice
Shvedova, A. A., Kisin, E. R., Mercer, R., Murray, A. R., Johnson, V. J., Potapovich, A. I., Tyurina, Y. Y., Gorelik, O., Arepalli, S., Schwegler-Berry, D., et al. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00084.2005 · Cited by 1,312
Lieber, M., Todaro, G., Smith, B., Szakal, A., & Nelson‐Rees, W. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910170110 · Cited by 1,283
Shvedova, A., Castranova, V., Kisin, E., Schwegler-Berry, D., Murray, A., Gandelsman, V., Maynard, A., & Baron, P. (2003) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/713853956 · Cited by 1,245
The biocompatibility of carbon nanotubes
Smart, S. K., Cassady, A. I., Lu, G. Q., & Martin, D. J. (2006) · Carbon · doi:10.1016/j.carbon.2005.10.011 · Cited by 1,011
Oops they did it again! Carbon nanotubes hoax scientists in viability assays
Wörle-Knirsch, J. M., Pulskamp, K., & Krug, H. F. (2006) · Nano Letters · doi:10.1021/nl060177c · Cited by 994 · cited 1×
“Another recent study has also reported SWCNT interference with the MTT assay (Wörle-Knirsch et al., 2006).”
ResultEffect of single wall carbon nanotubes on human HEK293 cells
Cui, D., Tian, F., Ozkan, C. S., Wang, M., & Gao, H. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2004.08.015 · Cited by 831
Cited by
Karlsson, H. L., Cronholm, P., Gustafsson, J., & Möller, L. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800064j · Cited by 1,480
NanoGenotoxicology: The DNA damaging potential of engineered nanomaterials
Singh, N., Manshian, B., Jenkins, G. J. S., Griffiths, S. M., Williams, P. M., Maffeis, T. G. G., Wright, C. J., & Doak, S. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.009 · Cited by 1,184
Toxicology and clinical potential of nanoparticles
Yildirimer, L., Thanh, N. T. K., Loizidou, M., & Seifalian, A. M. (2011) · Nano Today · doi:10.1016/j.nantod.2011.10.001 · Cited by 676
Shvedova, A. A., Kisin, E., Murray, A. R., Johnson, V. J., Gorelik, O., Arepalli, S., Hubbs, A. F., Mercer, R. R., Keohavong, P., Sussman, N., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90287.2008 · Cited by 641
Monteiro-Riviere, N. A., Inman, A. O., & Zhang, L. W. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.09.030 · Cited by 598
In vitro assessments of nanomaterial toxicity
Jones, C. F., & Grainger, D. W. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.005 · Cited by 554
Aranda, A., Sequedo, L., Tolosa, L., Quintas, G., Burello, E., Castell, J. V., & Gombau, L. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.01.016 · Cited by 487
Lanone, S., Rogerieux, F., Geys, J., Dupont, A., Maillot-Marechal, E., Boczkowski, J., Lacroix, G., & Hoet, P. (2009) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-6-14 · Cited by 468
Current in vitro methods in nanoparticle risk assessment: Limitations and challenges
Kroll, A., Pillukat, M. H., Hahn, D., & Schnekenburger, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.009 · Cited by 465
In vitro and in vivo toxicity assessment of nanoparticles
Kumar, V., Sharma, N., & Maitra, S. S. (2017) · International Nano Letters · doi:10.1007/s40089-017-0221-3 · Cited by 391
Testing Metal‐Oxide Nanomaterials for Human Safety
Landsiedel, R., Ma‐Hock, L., Kroll, A., Hahn, D., Schnekenburger, J., Wiench, K., & Wohlleben, W. (2010) · Advanced Materials · doi:10.1002/adma.200902658 · Cited by 387
Johnston, H. J., Hutchison, G. R., Christensen, F. M., Peters, S., Hankin, S., Aschberger, K., & Stone, V. (2010) · Nanotoxicology · doi:10.3109/17435390903569639 · Cited by 381
Alshehri, R., Ilyas, A. M., Hasan, A., Arnaout, A., Ahmed, F., & Memic, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01770 · Cited by 381
Foldvari, M., & Bagonluri, M. (2008) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.04.003 · Cited by 378
Multiwalled carbon nanotube–doxorubicin supramolecular complexes for cancer therapeutics
Ali-Boucetta, H., Al-Jamal, K. T., McCarthy, D., Prato, M., Bianco, A., & Kostarelos, K. (2008) · Chem. Commun. · doi:10.1039/b712350g · Cited by 372
Jacobsen, N. R., Pojana, G., White, P., Møller, P., Cohn, C. A., Smith Korsholm, K., Vogel, U., Marcomini, A., Loft, S., & Wallin, H. (2008) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20406 · Cited by 370
Health Concerns of Various Nanoparticles: A Review of Their in Vitro and in Vivo Toxicity
Ajdary, M., Moosavi, M. A., Rahmati, M., Falahati, M., Mahboubi, M., Mandegary, A., Jangjoo, S., Mohammadinejad, R., & Varma, R. S. (2018) · Nanomaterials · doi:10.3390/nano8090634 · Cited by 340
Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus?
Shvedova, A. A., Kisin, E. R., Porter, D., Schulte, P., Kagan, V. E., Fadeel, B., & Castranova, V. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.009 · Cited by 336
Garner, K. L., & Keller, A. A. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2503-2 · Cited by 330
Removal of copper from aqueous solution by carbon nanotube/calcium alginate composites
Li, Y., Liu, F., Xia, B., Du, Q., Zhang, P., Wang, D., Wang, Z., & Xia, Y. (2010) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2009.12.114 · Cited by 324
Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles
Singh, R. P., & Ramarao, P. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.009 · Cited by 321
Pulmonary applications and toxicity of engineered nanoparticles
Card, J. W., Zeldin, D. C., Bonner, J. C., & Nestmann, E. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00041.2008 · Cited by 307
Advancement in carbon nanotubes: basics, biomedical applications and toxicity
Beg, S., Rizwan, M., Sheikh, A. M., Hasnain, M. S., Anwer, K., & Kohli, K. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01167.x · Cited by 306
Fenoglio, I., Greco, G., Tomatis, M., Muller, J., Raymundo-Piñero, E., Béguin, F., Fonseca, A., Nagy, J. B., Lison, D., & Fubini, B. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800100s · Cited by 302
Clastogenic and aneugenic effects of multi-wall carbon nanotubes in epithelial cells
Muller, J., Decordier, I., Hoet, P. H., Lombaert, N., Thomassen, L., Huaux, F., Lison, D., & Kirsch-Volders, M. (2008) · Carcinogenesis · doi:10.1093/carcin/bgm243 · Cited by 298
Widespread Nanoparticle-Assay Interference: Implications for Nanotoxicity Testing
Ong, K. J., MacCormack, T. J., Clark, R. J., Ede, J. D., Ortega, V. A., Felix, L. C., Dang, M. K. M., Ma, G., Fenniri, H., Veinot, J. G. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090650 · Cited by 298
Carbon nanotubes: Evaluation of toxicity at biointerfaces
Mohanta, D., Patnaik, S., Sood, S., & Das, N. (2019) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2019.04.003 · Cited by 297
Casey, A., Herzog, E., Davoren, M., Lyng, F. M., Byrne, H. J., & Chambers, G. (2007) · Carbon · doi:10.1016/j.carbon.2007.03.033 · Cited by 296
Self-citationLindberg, H. K., Falck, G. C.-M., Suhonen, S., Vippola, M., Vanhala, E., Catalán, J., Savolainen, K., & Norppa, H. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2008.11.019 · Cited by 287
Critical Review on the Toxicity of Some Widely Used Engineered Nanoparticles
Srivastava, V., Gusain, D., & Sharma, Y. C. (2015) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.5b01610 · Cited by 277
Cell viability assessment using the Alamar blue assay: A comparison of 2D and 3D cell culture models
Bonnier, F., Keating, M. E., Wróbel, T. P., Majzner, K., Baranska, M., Garcia-Munoz, A., Blanco, A., & Byrne, H. J. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.09.014 · Cited by 276
Self-citationCarbon‐Based Nanomaterials for Tissue Engineering
Ku, S. H., Lee, M., & Park, C. B. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201200307 · Cited by 268
A new approach to the toxicity testing of carbon-based nanomaterials—The clonogenic assay
HERZOG, E., CASEY, A., LYNG, F., CHAMBERS, G., BYRNE, H., & DAVOREN, M. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.08.009 · Cited by 263
Self-citationMuller, J., Huaux, F., Fonseca, A., Nagy, J. B., Moreau, N., Delos, M., Raymundo-Piñero, E., Béguin, F., Kirsch-Volders, M., Fenoglio, I., et al. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800101p · Cited by 261
Aschberger, K., Johnston, H. J., Stone, V., Aitken, R. J., Hankin, S. M., Peters, S. A. K., Tran, C. L., & Christensen, F. M. (2010) · Critical Reviews in Toxicology · doi:10.3109/10408444.2010.506638 · Cited by 255
Perturbational profiling of nanomaterial biologic activity
Shaw, S. Y., Westly, E. C., Pittet, M. J., Subramanian, A., Schreiber, S. L., & Weissleder, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802878105 · Cited by 248
Nanotechnology—novel therapeutics for CNS disorders
Srikanth, M., & Kessler, J. A. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.76 · Cited by 198
Sanchez, V. C., Pietruska, J. R., Miselis, N. R., Hurt, R. H., & Kane, A. B. (2009) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.41 · Cited by 186
Bouwmeester, H., Lynch, I., marvin, H. J. P., Dawson, K. A., Berges, M., Braguer, D., Byrne, H. J., Casey, A., Chambers, G., Clift, M. J. D., et al. (2011) · Nanotoxicology · doi:10.3109/17435391003775266 · Cited by 131
Self-citationNagai, H., & Toyokuni, S. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02326.x · Cited by 98
Behan, B. L., DeWitt, D. G., Bogdanowicz, D. R., Koppes, A. N., Bale, S. S., & Thompson, D. M. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32939 · Cited by 56
Potential Uses of Carbon Nanotubes in The Medical Field: How Worried Should Patients Be?
Boczkowski, J., & Lanone, S. (2007) · Nanomedicine · doi:10.2217/17435889.2.4.407 · Cited by 39
Metadata
- Authors
- Davoren, M., Herzog, E., Casey, A., Cottineau, B., Chambers, G., Byrne, H. J., & Lyng, F. M.
- Venue
- Toxicology in Vitro
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 21
- Issue
- 3
- Pages
- 438-448
- ISSN
- 0887-2333 (ISSN-L)
- OpenAlex
- W2141883105
- Cited by
- 440
- References
- 36
- FWCI
- 19.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.